Trial Profile

Effect of Laparoscopic-Guided Transversus Abdominus Plane (TAP) Block on Opioid Consumption Using Dual-Adjunct Therapy With Dexmedetomidine and Dexamethasone Versus Liposomal Bupivacaine (Exparel®) Following Minimally Invasive Colorectal Surgery: A Single-Blinded Randomized Clinical Trial.

Status: Withdrawn prior to enrolment

Phase of Trial: Phase II

Latest Information Update: 10 Mar 2023

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Dexamethasone (Primary) ; Dexmedetomidine (Primary) ; Ropivacaine (Primary) ; Bupivacaine
Indications Postoperative pain
Focus Therapeutic Use
Acronyms TAP

03 Mar 2023 Status changed from recruiting to withdrawn prior to enrolment. No Accrual. PI left Institution.
01 Aug 2022 Status changed from not yet recruiting to recruiting.
21 Mar 2022 Planned initiation date changed from 1 Mar 2022 to 1 Jul 2022.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com